Research
Research Area
Area 1: Neurological Sciences
This area includes several research topics concerning the study and treatment of brain lesions. Specifically, some studies aim at the final clinical characterization and treatment of cognitive deficits in patients with focal brain damage resulting from stroke or subsequent to neurosurgical interventions. For example, memory disorders (amnesia) or language disorders (aphasia), in their different ways of clinical expression, once appropriately assessed are experimentally treated with a neuromodulation technique that involves the use of transcranial direct current stimulation (tDCS). Some experimental pharmacological studies are also active for patients affected by neurodegenerative diseases (e.g. Alzheimer's disease, Amyotrophic Lateral Sclerosis) or neuromuscular diseases (chronic inflammatory demyelinating polyneuropathy). At the Laboratory of Neurobiology for Translational Research, at Casa di Cura Igea, studies are underway aimed at evaluating the molecular mechanisms underlying cerebrovascular and neurodegenerative diseases, with particular attention to the possible identification of diagnostic and/or prognostic biomarkers. This type of study benefits from the presence at Casa di Cura Igea of the Biobank for the collection of biological samples from individuals affected by various neurological diseases or from healthy subjects.
Area 2: Neurorehabilitation Sciences
Research topics related to Neurorehabilitation Sciences occupy a relevant place in the context of our scientific activity. Active studies range from the application of new rehabilitation protocols to the use of new technologies and brain modulation. A series of retrospective researches have also been started on the data collected in recent years with the aim of studying the variations in the effectiveness of motor rehabilitation treatments in the presence of different cognitive deficits, and consequently optimizing the multidisciplinary management strategies of the Patient.
Area 3: Quality of life
In recent years, research has been launched to support the improvement of quality of life in the clinical-home care continuity pathway. These studies place particular attention on improving home care through the use of assistive technologies (such as sensors, artificial intelligence and robotics).
